Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

E-ISSN： 1873-4294|6|7|697-709

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.7, 2006-04, pp. : 697-709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

By McCauley John A

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 389-407

Informa Healthcare

Access to resources Recommend Favorite

NR2B Selective NMDA Receptor Antagonists

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite

NMDA receptor antagonists as analgesics: focus on the NR2B subtype

By Chizh B.A. Headley P.M. Tzschentke T.M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite

The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dt sz mutant

By Richter A.

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis

By Williams A.J. Dave J.R. Lu X.M. Ling G. Tortella F.C.

European Journal of Pharmacology, Vol. 452, Iss. 1, 2002-09 ,pp. : 135-136

Elsevier

Access to resources Recommend Favorite